Package 63868-103-24

{"route": ["ORAL"], "spl_id": "284c2e2c-017d-cc45-e063-6394a90a8d6a", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0635515987395"], "unii": ["362O9ITL9D", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1243679"], "spl_set_id": ["0955d856-cc4e-4ef2-8bc0-1a632a5b5f79"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (63868-103-24)  / 12 TABLET, COATED in 1 BLISTER PACK", "package_ndc": "63868-103-24", "marketing_start_date": "20220803"}], "brand_name": "Head Congestion Mucus PE", "product_id": "63868-103_284c2e2c-017d-cc45-e063-6394a90a8d6a", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "63868-103", "generic_name": "ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Head Congestion Mucus PE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20220803", "listing_expiration_date": "20261231"}